Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Reagents, Kits, and Consumables, Instruments, Software & Services
- By Type of Testing Laboratory Testing, POC Testing
- By Technology Immunodiagnostics, Clinical Microbiology , PCR , INAAT , DNA Sequencing & NGS , DNA Microarrays , Other technologies
- By Disease Type COVID-19, HIV , HAIs , Hepatitis , CT/NG , HPV , TB , Influenza , Other Infectious Diseases
- By End User Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 29632.56 Million |
Revenue 2030: | USD 49041.76 Million |
Revenue CAGR (2023 - 2030): | 6.50% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Infectious Disease Diagnostics Market by Product by Type of Testing by Technology by Disease Type by End User - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others.
Data Triangulation and Market Size Estimations
Top-down and bottom-up approaches are used to validate and estimate the market size of the Infectious Disease Diagnostics market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.
FAQ
Frequently Asked Question
What is the global demand for Infectious Disease Diagnostics in terms of revenue?
-
The global Infectious Disease Diagnostics valued at USD 29632.56 Million in 2022 and is expected to reach USD 49041.76 Million in 2030 growing at a CAGR of 6.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Infectious Disease Diagnostics include
- increasing prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Infectious Disease Diagnostics in 2022.